CHRONIC ARSENIC EXPOSURE AND ADVERSE HEALTH OUTCOME: UNDERSTANDING THE MOLECULAR PERSPECTIVES | 71803
Occupational Medicine & Health Affairs
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Chronic arsenic toxicity and its and its adverse health outcome including cancer (multiple target organs) is a well established
fact; however the underlying molecular mechanism of this non-mutagenic carcinogen is not well understood so far. Population
chronically exposed to arsenic, either through groundwater, food stuff or occupational sources, results in a plethora of dermatological
and non-dermatological health effects including multi-organ cancer and early mortality. Epidemiological studies identified males
are more affected; however risk of women and child were overlooked to some extent. Skin lesions are hallmarks of arsenic toxicity
and pre-malignant lesions like palmar and planter keratosis later develop into skin cancer. To understand the adverse effect of this
toxic metabolite on biological system (cellular targets) and to unravel the underlying molecular basis (at the level of transcript,
proteome, or metabolite) a holistic, systems biology approach was taken; where we assessed the arsenic exposure in the patients
sample (blood, urine, nail, hair), identified biomarkers (cellular, genetic as well as epigenetic) and correlated with altered functioning
of system (cardiovascular, respiratory, peripheral neuropathy, etc). It has been noticed, two individuals of same family member,
might have different disease outcome despite of exposure at similar extent, indicating variation in individual genomic landscape and
consequent interaction with environment. We have identified alterations in gene expression profile and epigenetic dysregulations
(including altered DNA methylation, histone code error and miRNA dysregulation) specifically for "arsenic signature" and "lesion
signature" patterns. These patterns can be used as potential prognostic biomarkers of arsenic toxicity. Moreover, we are investigating
the anti-carcinogenic and epigenetic potential of black tea on arsenic-induced cancer cell line, which could be promising as epigenetic
therapeutics in the field of arsenicosis.
Pritha Bhattacharjee is an Assistant Professor presently working in University of Calcutta, India. Her research interest includes Environmental Toxicogenomics, Molecular Biology and Human Genetics. She published many research articles in reputed scientific journals.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals